When 'Safe' Stocks Hide the Best LEAPS Setups

Here's a counterintuitive truth most retail traders never grasp: the stocks everyone runs to for safety are often the ones with the most criminally underpriced options. When institutional money rotates into minimum-volatility names — think utilities, consumer staples, low-beta healthcare — implied volatility on those tickers collapses. Premiums get cheap. Very cheap. And deep out-of-the-money LEAPS calls on large-cap, low-vol stocks can drop to literal cents on the dollar. The crowd is busy buying Vanguard's minimum volatility ETF (VFMV) for downside protection. Options traders with a longer time horizon should be looking at the underlying holdings and asking a different question entirely: what happens when these "boring" stocks stop being boring?

What's Actually Happening

The rotation into minimum-volatility equity strategies isn't just a retail phenomenon — it's a systematic institutional response to a macro environment that refuses to resolve cleanly. Sticky inflation, a Federal Reserve that's still in data-dependent limbo, and geopolitical risk premiums that haven't fully priced into equities are pushing allocators toward factor-based defensiveness. The Vanguard U.S. Minimum Volatility ETF (VFMV) and its peers are beneficiaries of this reallocation.

But here's what the fund-flow narrative misses: minimum volatility does not mean minimum movement. These strategies tilt toward stocks with historically lower beta — names like Johnson & Johnson (JNJ), Procter & Gamble (PG), Coca-Cola (KO), and select healthcare and utility plays. They don't move much in normal markets. But when the macro backdrop shifts — a Fed pivot, a sector-specific catalyst, an earnings surprise — these names can rip hard precisely because nobody is positioned for upside. The options market has no memory. It prices based on recent realized volatility, not tail scenarios. Right now, recent realized vol on these names is suppressed. That's the setup.

Why Options Traders Should Pay Attention

Implied volatility is the engine behind every options pricing model, and right now it's running cold on large-cap defensive names. When institutional money floods into a sector for safety reasons, it compresses both realized volatility and, with a lag, implied volatility on individual holdings. The options market interprets calm price action as a signal to lower its risk estimates. Premiums shrink. This is where things get interesting for traders who think in terms of asymmetric payoffs.

Consider the mechanics: if a name like Procter & Gamble (PG) is trading around $165 and has seen its 30-day realized vol drop to the low teens, the options market will price LEAPS contracts expiring in 12–18 months at relatively modest implied volatility. A deep OTM call — say, a $200 strike expiring in January 2026 — might be priced at just a few cents. That's not a typo. These contracts exist in the $0.01–$0.08 range on large-cap names with billions in daily trading volume.

The catalyst timing here matters enormously. The Federal Reserve's rate trajectory, if it pivots more aggressively than expected toward cuts in late 2025, would directly reprice the entire low-volatility factor. These stocks are implicitly rate-sensitive — they're often bought as bond proxies. A material drop in rates could cause a sharp, unexpected re-rating across the entire min-vol universe. Options that were priced for stagnation suddenly have a reason to move. Premium expansion happens fast. Holding a $0.03 call when implied volatility doubles is the kind of trade that changes portfolio math.

The LEAPS Angle

Let's get specific about what the LEAPS opportunity actually looks like inside minimum-volatility-adjacent large caps. The thesis has three legs: suppressed IV, long time horizon to absorb false starts, and a credible macro catalyst that the options market is currently underpricing.

Start with the time horizon. LEAPS — long-dated options expiring 12 to 24 months out — give traders runway that weekly or monthly options simply can't provide. If the Fed pivot trade takes longer to materialize than the market expects (which is almost always the case), a LEAPS position in January 2026 or January 2027 expiration doesn't blow up on you in three weeks. You're buying time as much as you're buying delta. On a $0.04 call, the maximum loss is already defined. That's the structure.

The specific names worth running through a scanner right now include the high-weight holdings in minimum-volatility strategies — consumer staples giants like Colgate-Palmolive (CL), healthcare names like Abbott Laboratories (ABT), and select utility plays where options liquidity is sufficient for LEAPS. The key filter is finding strikes that are deep enough OTM to be priced below $0.08 but not so far out that delta approaches zero. That sweet spot — typically 20–35% above current price with 12–18 months to expiration — is where the asymmetry lives.

This is exactly the type of setup that traders use StrikeEdge to surface. The scanner is built specifically to identify deep OTM LEAPS calls priced $0.01–$0.08 on large-cap stocks, filtering for the low-premium, high-leverage scenarios that are nearly impossible to find manually across hundreds of tickers. When a macro theme like the min-vol rotation is in play, running VFMV's top holdings through that kind of systematic scan can surface 3–5 setups that would otherwise take hours to find. The edge isn't the idea — it's the execution speed.

Realistic scenario modeling matters here. A $0.04 call that moves to $0.40 on a 15% underlying move is a 10x return on premium. That doesn't require a moonshot. It requires the stock to catch a bid that nobody positioned for.

Key Risks to Watch

None of this works if the macro thesis stalls indefinitely. The primary risk to the min-vol LEAPS setup is exactly what makes these stocks attractive to defensive investors in the first place: they don't move. If the Fed stays higher for longer into 2026, if inflation reaccelerates, or if risk appetite returns and capital rotates back into growth names — these defensive stocks could grind sideways for an extended period. LEAPS have time value, but they're not immune to theta decay. A position entered at $0.04 that sits dormant for 9 months is still losing value, even if the underlying hasn't crashed.

Liquidity is the second risk. Deep OTM LEAPS on consumer staples names often have wide bid-ask spreads and thin open interest. Entering a position at $0.04 with a $0.02 spread means you're immediately down 50% on paper. Size accordingly. These are lottery-ticket-sized position allocations — meaningful in percentage return, not in absolute capital commitment.

• Fed trajectory risk: Higher-for-longer kills the rate-sensitive re-rating thesis
• Liquidity risk: Thin markets on deep OTM contracts amplify slippage
• Time decay: Theta erosion accelerates in the final 90 days — have an exit plan
• Catalyst delay: Being right 13 months too late still means a loss

The Takeaway

The defensive rotation into minimum-volatility strategies is a macro story. But inside that story is a micro opportunity that most traders will completely ignore. When implied volatility gets suppressed across large-cap, low-beta names, deep OTM LEAPS calls get cheap enough to offer extraordinary asymmetry for a defined, small premium. The setup isn't about predicting the market. It's about finding places where the options market has underpriced a credible scenario — and positioning before the crowd catches on. Run the holdings. Check the premiums. The $0.04 calls on household-name stocks don't stay at $0.04 forever.